3gen manufactures the DermLite brand of skin imaging devices.
AbbVie is a global, research-based biopharmaceutical company, which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Biofrontera specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused both by exposure to sunlight that results in sun damage to the skin and bacterial skin infections.
Focused on transforming the delivery of care, Barco connects healthcare professionals at every patient touch point, from the imaging room, to radiology, through specialist consultations and in the surgical suite. We offer a network of medical imaging solutions that deliver the complete picture to support more informed decisions, when and where it matters most.
Cassiopea, Inc. is a clinical-stage pharmaceutical company developing and commercializing innovative medical dermatology products, including a pipeline of topical androgen receptor inhibitor products, using a new chemical entity called clascoterone.
Our commitment to Dermatology is built around a senior leadership team with deep roots and experience in the specialty. The management team is focused on providing unique treatment options, and to drive continued research and development in Dermatology, moving us to the forefront of the U.S. market.
Clarify Medical is a private San Diego-based medical device company focused on developing innovative technology, products and services that improve care for people with chronic skin conditions. Its Clarify Home Phototherapy System is now available nationally in the U.S. Learn more at www.clarifymed.com.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, and deliver better care.
EPI Health is a growing specialty company in Charleston, SC with a focus on dermatology. Our goal is to develop and acquire best-in-class skin care solutions for unmet medical needs.
Galderma, Nestlé Skin Health’s medical solutions business, was created in 1981 and is now present in more than 100 countries, with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit www.galdermausa.com and www.galderma.com
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Janssen Biotech, Inc., a member of Janssen Pharmaceutical Companies of Johnson & Johnson, delivers on the promise of new treatments and ways to improve the health of individuals with serious disease. Built upon a legacy of innovative firsts, Janssen Biotech pursues advancing patient care with immunology and oncology solutions.
Legally Mine is an asset protection and tax strategy group. The mission of Legally Mine is to empower members of the healthcare and business communities with the knowledge and tools to protect their assets from lawsuits, build professional license safeguards into their legal structures and legitimately reduce their tax liability.
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels
MC2 Therapeutics is a privately held pharmaceutical company committed to bringing a new standard of topical therapies for chronic inflammatory conditions designed for fast relief of symptoms and convenience in daily routines. Our proprietary PAD™ Technology allows us to go beyond the technical limitations of conventional aqueous formulations and develop a new standard of innovative PAD™ Creams and PAD™ Eye Drops that are designed to become life companions for people with chronic inflammatory skin or eye conditions. PAD™ Technology enables PAD™ Creams to be formulated with far fewer surfactants compared to conventional creams and lotions allowing us to create creams that demonstrate great tolerability. In addition to our pipeline of PAD™ Cream based drugs we are launching a novel non-drug PAD™ Cream based skin care line BioMee™ designed specifically for dry and sensitive skin.
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105,000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
From its beginning, Person & Covey, Inc. has worked closely with the medical community to develop high-quality therapeutic formulas, especially in the areas of sun protection and dermatological care. Recognizing that each patient is unique, Person & Covey, Inc. carefully crafts products that are appropriate for use by even the most sensitive of users.
Ortho Dermatologics is committed to the dermatology community and healthcare providers, by helping treat patients in therapeutic areas including acne, immunology and psoriasis. Learn more at www.ortho-dermatologics.com.
Ra Medical Systems, Inc., markets the Pharos, Optimized, an advanced 308-nm UVB excimer laser for psoriasis, vitiligo, atopic dermatitis, and leukoderma. It is fast, safe, and powerful for difficult-to-treat psoriasis including scalp, palms and soles, and intertriginous lesions and for localized vitiligo, including facial and peri-orbital areas.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Our medicines and pipeline are designed to help patients with eye disease, heart disease, allergic and inflammatory diseases, pain, cancer, infectious diseases and rare diseases Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering.
SPII is a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd, a global specialty generic company based in Mumbai, which provides innovative, high-quality, affordable medicines trusted by customers and patients in over 150 countries around the world. It fosters excellence through innovation, supported by strong R&D capabilities, with approximately 2,000 scientists on staff and R&D investments of approximately 8% of annual revenues. It has been marketing its products in the US market for more than 20 years, providing generics, branded generics and over-the-counter products, and has distribution and customer service teams throughout the US. For further information, please visit www.sunpharma.com and follow us on Twitter at @SunPharma_Live
Stemline Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. ELZONRIS (tagraxofusp), a CD123 targeted therapy, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
At UCB, we have a passionate, long-term commitment to discovering and developing innovative medicines that transform the lives of people living with severe immunological diseases and central nervous system disorders. With 8,500 employees in 40 countries, we invest more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs.